In oncology, we strive for cure and short of that, we strive
for stability. In some instances, particularly with recurrent disease, cure is
rare, and the process of curative treatment can be quite extreme (for example, bone
marrow transplantation for recurrent lymphoma, with the real risk of graft
versus host disease substantial and, in its most extreme, debilitating). But in
solid tumor oncology (for the most part), we have been driven toward less-toxic
treatments, less-complicated regimens, while continuing to strive for better
survival.
Welcome to Discussions with Don S. Dizon
Don S. Dizon, MD, FACP, is a medical oncologist who specializes in gynecologic oncology at the Massachusetts General Hospital (MGH) Cancer Center. Dr. Dizon also directs MGH’s Oncology Sexual Health Clinic, which he founded in 2013.
Thursday, June 15, 2017
Thursday, May 25, 2017
Cancer as a Chronic Disease
I remember as a kid, my grandmother would spend time at our
breakfast table reading the newspaper. Not cover to cover, mind you—she seemed
to always focus her attention on the obituaries. Sometimes she would look up
and tell anyone sitting around her about the death of someone near her age, or
sometimes, someone very young. It was the first time I remember hearing how
someone “lost the fight to cancer.” It is something I have heard many times
since, and it continues to bother me. I’ve written before how the war analogy
implies winners and losers, but even more than that, the analogy assumes only
two outcomes: remission or death. No middle ground. And today more than ever,
nothing is further from reality.
Tuesday, April 25, 2017
Being Human
When I was a resident, my colleagues chided me for wanting
to be an oncologist. Back then (and it pains
me to be old enough to use that phrase, by the way), oncology was thought of as
a field of futility. We administered toxic drugs to sick patients, who far more
often than not would die of the cancer or from our treatments. The disease was
cruel, and to many, oncologists didn’t really help; they only prolonged
suffering. Of course, I never saw oncology in that light—I came in to this
field to help us do better. To me, being an oncologist would be a privilege—to
help people through such a difficult diagnosis, and to stay with them through
whatever happened next. It was primary care at its most extreme.
Tuesday, March 14, 2017
What’s in a Word?
I’ve written in the past about how words are powerful—that
they can have multiple meanings, and how they can change depending on context.
I am often reminded about how true that is in every day oncology practice,
especially when it comes to meeting new patients. Some are diagnosed with
cancers that carry a relatively good prognosis, in which case there is reason
for an optimistic outlook and of “curative” treatment. Others have more
advanced disease or a poorer prognosis, in which case I tend to be more
cautious with the words I choose: “remission,” “stability,” “progression free,”
yes, but “cure” is a word I rarely use.